FibroGen News

FibroGen | 4: Statement of changes in beneficial ownership of securities-Officer Wettig Thane

Mar 25 17:59 ET

FibroGen | 4: Statement of changes in beneficial ownership of securities-Officer Wettig Thane

Mar 11 19:08 ET

FibroGen | 4: Statement of changes in beneficial ownership of securities-Officer Graham Juan

Mar 8 19:22 ET

FibroGen | 4: Statement of changes in beneficial ownership of securities-Officer Wettig Thane

Mar 8 19:22 ET

FibroGen | 4: Statement of changes in beneficial ownership of securities-Officer Chung Christine

Mar 8 19:22 ET

FibroGen | 4: Statement of changes in beneficial ownership of securities-Officer Wettig Thane

Feb 23 20:36 ET

FibroGen | 4: Statement of changes in beneficial ownership of securities-Officer Chung Christine

Feb 23 20:31 ET

FibroGen | 4: Statement of changes in beneficial ownership of securities-Officer Graham Juan

Feb 23 20:30 ET

FibroGen | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.93%),Steven Boyd(9.93%)

Feb 14 15:44 ET

FibroGen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Steven A. Cohen(1.7%),Point72 Asset Management, L.P.(1.6%), etc.

Feb 14 10:13 ET

FibroGen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(7.16%)

Feb 13 18:04 ET

FibroGen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-PRIMECAP Management Company(14.72%)

Feb 12 16:05 ET

FibroGen | 4: Statement of changes in beneficial ownership of securities-Officer Wettig Thane

Feb 5 20:14 ET

FibroGen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(7.3%)

Jan 26 16:26 ET

FibroGen | 4: Statement of changes in beneficial ownership of securities-CEO Wettig Thane

Dec 26, 2023 00:00 ET

FibroGen | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Graham Juan

Dec 11, 2023 16:21 ET

FibroGen | 4: Statement of changes in beneficial ownership of securities-Officer Chung Christine

Dec 11, 2023 16:20 ET

FibroGen | 4: Statement of changes in beneficial ownership of securities-CEO Wettig Thane

Dec 11, 2023 16:19 ET

FibroGen | 4: Statement of changes in beneficial ownership of securities-CEO Wettig Thane

Nov 3, 2023 16:20 ET

FibroGen | 4: Statement of changes in beneficial ownership of securities-Officer Wettig Thane

Sep 25, 2023 19:37 ET